drugset
drugset / Trial / NCT04082741

A Single and Multiple Ascending Dose Study of BMS-986318 in Healthy Participants

NCT04082741 ↗

Phase 1 Withdrawn Bristol-Myers Squibb
RandomizedParallel-groupDouble-blindTreatment

Summary

A study to evaluate single and multiple ascending doses of experimental medicine BMS-986318 in healthy participants.

Timeline

Start
2019-07-18
Primary completion
2019-09-12
Completion
2019-09-12

Outcome

Outcome not reported

Stopped: “The study is no longer required based on nonclinical drug data”

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-986318 Unknown — Oral

Indications

No indication recorded.